Biocon Biologics successfully integrates acquired biosimilars business across 120 countries Read more
Zydus receives USFDA approval to initiate Phase II clinical trial of ZYIL1 for Parkinson’s disease Read more
Median Technologies partners with PASREL-Imagerie to deliver imaging biomarkers for oncology drugs Read more